Mental Health Technician Certification (AMCA) Practice Test

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the Mental Health Technician Certification (AMCA) Test. Utilize flashcards, multiple choice questions with hints and explanations, and gear up for your exam success!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


What are the symptoms of Tardive Dyskinesia that a provider should monitor in a long-term antipsychotic medication user?

  1. Repetitious, involuntary muscle movements in the face and extremities

  2. Excessive sweating and nausea

  3. Memory loss and confusion

  4. Anxiety and agitation

The correct answer is: Repetitious, involuntary muscle movements in the face and extremities

The symptoms of Tardive Dyskinesia (TD) that should be monitored in a long-term antipsychotic medication user primarily involve involuntary and repetitious muscle movements, particularly affecting the face and extremities. This can manifest as grimacing, lip smacking, tongue protrusion, and jerking movements of the arms and legs. These involuntary movements are often a result of prolonged exposure to certain antipsychotic drugs, particularly first-generation antipsychotics, and can significantly impact a person’s quality of life. The other options provided do not accurately reflect the core symptoms associated with Tardive Dyskinesia. Excessive sweating and nausea are more commonly linked with other medication side effects or anxiety-related conditions rather than TD itself. Memory loss and confusion can indicate cognitive side effects or other psychiatric conditions but are not characteristic of TD. Lastly, anxiety and agitation are emotional or psychological symptoms that may arise in various contexts but are not indicative of Tardive Dyskinesia. Understanding the correct symptoms is crucial for early detection and management of TD in patients receiving long-term antipsychotic treatment.